Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
07/21/2004 | EP1438057A2 Pine cone extracts and uses thereof |
07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
07/21/2004 | EP1379643A4 Methods for identifying and purifying smooth muscle progenitor cells |
07/21/2004 | EP1283668A4 Nucleic acids that control plant development |
07/21/2004 | EP1232203B1 3d matrix for producing cell transplants |
07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
07/21/2004 | EP1127146B1 Novel expression cassette for expressing genes in plant seed |
07/21/2004 | EP0970247B1 Detection of dna damaging agents |
07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
07/21/2004 | EP0948604B1 Screening methods for compounds binding to the Pyk2 polypeptide |
07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
07/21/2004 | EP0815224B1 Receptor activation by gas6 |
07/21/2004 | EP0635030B1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS |
07/21/2004 | CN1514879A Moraxella (branhamella) catarrhalis antigens |
07/21/2004 | CN1514878A Method for detecting calpain 3 activity in biological sample and peptides for implementsing said method |
07/21/2004 | CN1514877A Method for autologous transplantation |
07/21/2004 | CN1514734A Composition and method for increasing cell density in cell cultures infected with lentivirus |
07/21/2004 | CN1514688A Oncolytic virus therapy |
07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
07/21/2004 | CN1513990A Plant gene promotor for quickly inducing defect stimulation and high efficienly expression |
07/21/2004 | CN1513986A Gene engineering method for raising plant useful secondary substance content |
07/21/2004 | CN1513985A Human embryo kidney 293 cell subclone cell strain |
07/21/2004 | CN1513564A Germ interstitial antisenility technology |
07/21/2004 | CN1158388C Technological process of continuously perfused culture of hybrid tumor cell to prepare antibody |
07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
07/20/2004 | US6765132 Inbred maize line PH26N |
07/20/2004 | US6765088 Immunological detection of prions |
07/20/2004 | US6765085 Polypeptide for use in the amplified propagation of crop plants |
07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
07/20/2004 | US6764854 Propagating plants; obtain spore, expose to stress, incubate with inducer, recover and culture spore |
07/20/2004 | US6764851 To provide plant cell, a plant tissue, a plant organ and a plant in which the level of acetyl coa has been altered |
07/20/2004 | US6764844 Used for manufacture of epimerases |
07/20/2004 | US6764843 Method of cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease |
07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
07/20/2004 | US6764835 Saturation mutageneis in directed evolution |
07/20/2004 | US6764827 For detection and measurement of serine proteases found in granulocytes |
07/20/2004 | US6764688 Culturing human peripheral blood cells in device coated with anti-cd3 antibody and an f(ab)2 fragment of the anti- cd2 antibody ts2/18 produced from hybridoma hb-195 |
07/20/2004 | US6764686 Modified immunogenic pneumolysin compositions as vaccines |
07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
07/20/2004 | CA2246456C Lipids and their use, for example, in liposomes |
07/15/2004 | WO2004058980A2 Plants having modified growth characteristics and a method for making the same |
07/15/2004 | WO2004058967A1 METHOD OF β1,4-GALACTOSYLATING GLYCAN HAVING N-ACETYLGLUCOSAMINE-6-SULFATE STRUCTURE |
07/15/2004 | WO2004058965A1 Method of separating precursor cells producing gabaergic nerve cells alone |
07/15/2004 | WO2004058964A1 Method of inducing homologous recombination of somatic cell |
07/15/2004 | WO2004058952A1 Method of culturing autologous cell using injectable solid powder |
07/15/2004 | WO2004058940A2 Sirna-mediated gene silencing |
07/15/2004 | WO2004058800A2 Mammalian cell culture processes for protein production |
07/15/2004 | WO2004058323A2 Directly injectable formulations which provide enhanced cryoprotection of cell products |
07/15/2004 | WO2004058305A2 Encapsulated cell for therapy |
07/15/2004 | WO2004058175A2 Novel use of liver x receptor agonists |
07/15/2004 | WO2004058154A2 Method of identifying therapeutic agents |
07/15/2004 | WO2004057968A1 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
07/15/2004 | WO2004057940A2 Canine dioxin/aryl hydrocarbon receptor sequences |
07/15/2004 | WO2004046322A3 Replication of biological tiussue |
07/15/2004 | WO2004046320A3 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
07/15/2004 | WO2004044149A3 Method for suppressing immune system response to transplanted tissue or cells |
07/15/2004 | WO2004042027A3 Allele-specific rna interference |
07/15/2004 | WO2004042010A3 Modified luciferase nucleic acids and methods of use |
07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
07/15/2004 | WO2004033634A3 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
07/15/2004 | WO2004031224A3 Hbv mutations associated with reduced susceptibility to adefovir |
07/15/2004 | WO2004027048A3 High titer recombinant aav production |
07/15/2004 | WO2004019878A3 Adzymes and uses thereof |
07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
07/15/2004 | WO2003100034A3 Dentritic cell nodes |
07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
07/15/2004 | WO2003092715A3 Proteins involved in the regulation of energy homeostasis |
07/15/2004 | WO2003078606A3 In vitro transfection and long-term cultivation of isolated organs |
07/15/2004 | WO2003078586A3 Vascularized tissue for transplantation |
07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
07/15/2004 | WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. |
07/15/2004 | WO2003068938A3 Human fetal bladder-derived epithelial cells |
07/15/2004 | WO2003063893B1 Fgfr agonists |
07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
07/15/2004 | WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
07/15/2004 | WO2002066613A3 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
07/15/2004 | WO2002018619A3 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
07/15/2004 | US20040139504 Suppression of specific classes of soybean seed protein genes |
07/15/2004 | US20040139503 Suppression of specific classes of soybean seed protein genes |
07/15/2004 | US20040139502 Suppression of specific classes of soybean seed protein genes |
07/15/2004 | US20040139501 Expression vector coding linalool synthase (LIS)promoter for use as tool in controlling tissue directed heterologous gene expression in plants; tissue engineering |
07/15/2004 | US20040139500 Plastid division and related genes and proteins, and methods of use |
07/15/2004 | US20040139499 encoded by a nucleic acid isolated from a Euphorbia lagascae developing seed cDNA library; chimeras; genetic engineering |
07/15/2004 | US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control |
07/15/2004 | US20040139488 Compositions and methods for enhancing disease resistance in fish |
07/15/2004 | US20040139486 Interstitial prostatism model animal |
07/15/2004 | US20040138822 Conditioning, preserving and storing for reuse; constituting and enhancing personal library |
07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
07/15/2004 | US20040138421 ACPL DNA and polypeptides |
07/15/2004 | US20040138420 Fluorescent proteins |
07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
07/15/2004 | US20040138414 Secreted proteins |
07/15/2004 | US20040138329 Gels for encapsulation of biological materials |
07/15/2004 | US20040138285 Low molecular weight compound and MEK1 inhibitor; bone disorders; osteoarthritis, arthritis |